Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.
The classification of Intranasal Drug Delivery Devices includes Multidose and Uni/bidose, and the proportion of Multidose in 2017 is about 85%, and the proportion is in decreasing trend from 2013 to 2017.
North America, especially The United States, will still play an important role which cannot be ignored, with market size of 340 million USD in 2017 and will be 770 million USD in 2025. Any changes from United States might affect the development trend of Intranasal Drug Delivery Devices. North America region is the largest consumer of Intranasal Drug Delivery Devices, with a market share nearly 43% in 2017.
Europe also plays important roles in global market, with market size of 270 million USD in 2017, enjoying sales market share nearly 34% in 2017.The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
The global Intranasal Drug Delivery market is valued at 780 million US$ in 2018 is expected to reach 1730 million US$ by the end of 2025, growing at a CAGR of 10.5% during 2019-2025.
This report focuses on Intranasal Drug Delivery volume and value at global level, regional level and company level. From a global perspective, this report represents overall Intranasal Drug Delivery market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
BD
AptarGroup
3M
Teleflex
H&T Presspart
Bespak
Pfizer
Novartis
Becton Dickinson
Johnson & Johnson
Merck
GlaxoSmithKline
Nemera
OptiNose
AstraZeneca
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Multidose
Uni/bidose
Segment by Application
Personal Use
Hospital Use
Summary:
Get latest Market Research Reports on Intranasal Drug Delivery. Industry analysis & Market Report on Intranasal Drug Delivery is a syndicated market report, published as Global Intranasal Drug Delivery Market Research Report 2019. It is complete Research Study and Industry Analysis of Intranasal Drug Delivery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.